Search - tctmd.com

Displaying 981 - 1000 of 1348

Sort: Relevancy | Date

News Daily News

Longer Ischemic Times in Women with STEMI Due to Age, Comorbidities

Yael L. Maxwell

December 05, 2012

News Daily News

Un Test Podría Detectar qué Pacientes STEMI corren Riesgo de sufrir Nefropatía por Contraste tras someterse a una PCI

Jason Kahn

December 03, 2012

News Daily News

Test May Detect STEMI Patients at Risk for Contrast Nephropathy After PCI

Jason Kahn

December 03, 2012

News Daily News

Análisis CREST: los accidentes cerebrovasculares son poco comunes después de

Jason Kahn

December 02, 2012

News Daily News

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

November 28, 2012

News Daily News

Meta-análisis cuestiona beneficio de la terapia antiplaquetaria doble extendida después la PCI

November 28, 2012

News Daily News

Study Shows Impact of Public Health Communication on Clopidogrel Use Post DES

November 20, 2012

News Daily News

Estudio muestra el impacto de la comunicación de salud pública en el uso de clopidogrel después de la colocación de un SLF

November 20, 2012

News Conference News TCT 2012

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

November 18, 2012

News Daily News

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

November 13, 2012

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

News Conference News AHA 2012

OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia

Jason Kahn

November 06, 2012

News Industry News

Significant Blood Pressure Reduction from St. Jude Medical's EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months

November 04, 2012

News Conference News AHA 2012

Platelet Reactivity in Response to Prasugrel Depends on the Test

November 04, 2012

News Conference News AHA 2012

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

Jason Kahn

November 04, 2012

Presentation AHA 2012

FREEDOM Trial Main Results

Presenter: Valentin Fuster

November 04, 2012

News Conference News AHA 2012

Pair of Studies Look at Cost Effectiveness of PCI in Different Populations

Jason Kahn

November 04, 2012

News Conference News AHA 2012

FREEDOM: CABG Superior to PCI in Diabetic Patients with Multivessel Disease

November 04, 2012

News Conference News TCT 2012

COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial

November 02, 2012

News Conference News TCT 2012

Biomarkers May Identify Risky Subcritical Lesions

October 30, 2012

Advertisement

Longer Ischemic Times in Women with STEMI Due to Age, Comorbidities

Un Test Podría Detectar qué Pacientes STEMI corren Riesgo de sufrir Nefropatía por Contraste tras someterse a una PCI

Test May Detect STEMI Patients at Risk for Contrast Nephropathy After PCI

Análisis CREST: los accidentes cerebrovasculares son poco comunes después de

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

Meta-análisis cuestiona beneficio de la terapia antiplaquetaria doble extendida después la PCI

Study Shows Impact of Public Health Communication on Clopidogrel Use Post DES

Estudio muestra el impacto de la comunicación de salud pública en el uso de clopidogrel después de la colocación de un SLF

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia

Significant Blood Pressure Reduction from St. Jude Medical's EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months

Platelet Reactivity in Response to Prasugrel Depends on the Test

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

FREEDOM Trial Main Results

Pair of Studies Look at Cost Effectiveness of PCI in Different Populations

FREEDOM: CABG Superior to PCI in Diabetic Patients with Multivessel Disease

COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial

Biomarkers May Identify Risky Subcritical Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content